Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study

Objective To firstly examine the relationship between serum brain-derived neurotrophic factor (BDNF) levels and antidepressant response to ketamine as an anaesthesia in electroconvulsive therapy (ECT) in Chinese patients with treatment-refractory depression (TRD). Methods Thirty patients with TRD we...

Full description

Bibliographic Details
Main Authors: Wei Zheng, Qiaomei Cen, Sha Nie, Minyi Li, Rong Zeng, Sumiao Zhou, Dongbin Cai, Miaoling Jiang, Xiong Huang
Format: Article
Language:English
Published: PeerJ Inc. 2021-02-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/10699.pdf
_version_ 1797418694121357312
author Wei Zheng
Qiaomei Cen
Sha Nie
Minyi Li
Rong Zeng
Sumiao Zhou
Dongbin Cai
Miaoling Jiang
Xiong Huang
author_facet Wei Zheng
Qiaomei Cen
Sha Nie
Minyi Li
Rong Zeng
Sumiao Zhou
Dongbin Cai
Miaoling Jiang
Xiong Huang
author_sort Wei Zheng
collection DOAJ
description Objective To firstly examine the relationship between serum brain-derived neurotrophic factor (BDNF) levels and antidepressant response to ketamine as an anaesthesia in electroconvulsive therapy (ECT) in Chinese patients with treatment-refractory depression (TRD). Methods Thirty patients with TRD were enrolled and underwent eight ECT sessions with ketamine anaesthesia (0.8 mg/kg) alone. Depression severity, response and remission were evaluated using the 17-item Hamilton Depression Rating Scale (HAMD-17). Enzyme-linked immunosorbent assay (ELISA) was applied to examine serum BDNF levels in patients with TRD at baseline and after the second, fourth and eighth ECT sessions. Baseline serum samples were also collected for 30 healthy controls. Results No significant differences were observed in serum BDNF levels between patients with TRD and healthy controls at baseline (p > 0.05). The remission rate was 76.7% (23/30) after the last ECT treatment, although all patients with TRD obtained antidepressant response criteria. Serum BDNF levels were not altered compared to baseline, even between remitters and nonremitters (all p > 0.05), despite the significant reduction in HAMD-17 and Brief Psychiatric Rating Scale (BPRS) scores after ECT with ketamine anaesthesia (all p < 0.05). The antidepressant effects of ECT with ketamine anaesthesia were not correlated with changes in serum BDNF levels (all p > 0.05). Conclusion This preliminary study indicated that serum BDNF levels do not appear to be a reliable biomarker to determine the antidepressant effects of ketamine as an anaesthesia in ECT for patients with TRD. Further studies with larger sample sizes are warranted to confirm these findings.
first_indexed 2024-03-09T06:36:39Z
format Article
id doaj.art-da131e3e1df64370a1696795672b4c21
institution Directory Open Access Journal
issn 2167-8359
language English
last_indexed 2024-03-09T06:36:39Z
publishDate 2021-02-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj.art-da131e3e1df64370a1696795672b4c212023-12-03T10:57:29ZengPeerJ Inc.PeerJ2167-83592021-02-019e1069910.7717/peerj.10699Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary studyWei Zheng0Qiaomei Cen1Sha Nie2Minyi Li3Rong Zeng4Sumiao Zhou5Dongbin Cai6Miaoling Jiang7Xiong Huang8The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, ChinaThe Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, ChinaThe Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, ChinaThe Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, ChinaThe Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, ChinaThe Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, ChinaShenzhen Traditional Chinese Medicine Hospital, Shenzhen, ChinaThe Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, ChinaThe Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, ChinaObjective To firstly examine the relationship between serum brain-derived neurotrophic factor (BDNF) levels and antidepressant response to ketamine as an anaesthesia in electroconvulsive therapy (ECT) in Chinese patients with treatment-refractory depression (TRD). Methods Thirty patients with TRD were enrolled and underwent eight ECT sessions with ketamine anaesthesia (0.8 mg/kg) alone. Depression severity, response and remission were evaluated using the 17-item Hamilton Depression Rating Scale (HAMD-17). Enzyme-linked immunosorbent assay (ELISA) was applied to examine serum BDNF levels in patients with TRD at baseline and after the second, fourth and eighth ECT sessions. Baseline serum samples were also collected for 30 healthy controls. Results No significant differences were observed in serum BDNF levels between patients with TRD and healthy controls at baseline (p > 0.05). The remission rate was 76.7% (23/30) after the last ECT treatment, although all patients with TRD obtained antidepressant response criteria. Serum BDNF levels were not altered compared to baseline, even between remitters and nonremitters (all p > 0.05), despite the significant reduction in HAMD-17 and Brief Psychiatric Rating Scale (BPRS) scores after ECT with ketamine anaesthesia (all p < 0.05). The antidepressant effects of ECT with ketamine anaesthesia were not correlated with changes in serum BDNF levels (all p > 0.05). Conclusion This preliminary study indicated that serum BDNF levels do not appear to be a reliable biomarker to determine the antidepressant effects of ketamine as an anaesthesia in ECT for patients with TRD. Further studies with larger sample sizes are warranted to confirm these findings.https://peerj.com/articles/10699.pdfElectroconvulsive therapyKetamineDepressionBrain-derived neurotrophic factor
spellingShingle Wei Zheng
Qiaomei Cen
Sha Nie
Minyi Li
Rong Zeng
Sumiao Zhou
Dongbin Cai
Miaoling Jiang
Xiong Huang
Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study
PeerJ
Electroconvulsive therapy
Ketamine
Depression
Brain-derived neurotrophic factor
title Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study
title_full Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study
title_fullStr Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study
title_full_unstemmed Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study
title_short Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study
title_sort serum bdnf levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia a preliminary study
topic Electroconvulsive therapy
Ketamine
Depression
Brain-derived neurotrophic factor
url https://peerj.com/articles/10699.pdf
work_keys_str_mv AT weizheng serumbdnflevelsandtheantidepressanteffectsofelectroconvulsivetherapywithketamineanaesthesiaapreliminarystudy
AT qiaomeicen serumbdnflevelsandtheantidepressanteffectsofelectroconvulsivetherapywithketamineanaesthesiaapreliminarystudy
AT shanie serumbdnflevelsandtheantidepressanteffectsofelectroconvulsivetherapywithketamineanaesthesiaapreliminarystudy
AT minyili serumbdnflevelsandtheantidepressanteffectsofelectroconvulsivetherapywithketamineanaesthesiaapreliminarystudy
AT rongzeng serumbdnflevelsandtheantidepressanteffectsofelectroconvulsivetherapywithketamineanaesthesiaapreliminarystudy
AT sumiaozhou serumbdnflevelsandtheantidepressanteffectsofelectroconvulsivetherapywithketamineanaesthesiaapreliminarystudy
AT dongbincai serumbdnflevelsandtheantidepressanteffectsofelectroconvulsivetherapywithketamineanaesthesiaapreliminarystudy
AT miaolingjiang serumbdnflevelsandtheantidepressanteffectsofelectroconvulsivetherapywithketamineanaesthesiaapreliminarystudy
AT xionghuang serumbdnflevelsandtheantidepressanteffectsofelectroconvulsivetherapywithketamineanaesthesiaapreliminarystudy